S Larkin

2.2k total citations
26 papers, 1.9k citations indexed

About

S Larkin is a scholar working on Cellular and Molecular Neuroscience, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S Larkin has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 10 papers in Physiology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S Larkin's work include Neuropeptides and Animal Physiology (10 papers), Nitric Oxide and Endothelin Effects (9 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers). S Larkin is often cited by papers focused on Neuropeptides and Animal Physiology (10 papers), Nitric Oxide and Endothelin Effects (9 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers). S Larkin collaborates with scholars based in United Kingdom, United States and Bulgaria. S Larkin's co-authors include Jane A. Mitchell, Timothy J. Williams, A Maseri, Graham J. Davies, T.J. Williams, John Clarke, David Bishop‐Bailey, D. Hackett, Nigel Benjamin and Sergio Chierchia and has published in prestigious journals such as The Lancet, Circulation and The Journal of Experimental Medicine.

In The Last Decade

S Larkin

26 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Larkin United Kingdom 20 627 604 459 435 378 26 1.9k
Hideki Okunishi Japan 25 354 0.6× 788 1.3× 687 1.5× 350 0.8× 429 1.1× 97 2.3k
Renhui Yang United States 28 535 0.9× 968 1.6× 1.3k 2.8× 151 0.3× 319 0.8× 64 2.9k
Matthew J. Brody United States 26 398 0.6× 979 1.6× 1.0k 2.2× 185 0.4× 396 1.0× 52 2.3k
Marie‐Hélène Séguélas France 18 232 0.4× 370 0.6× 876 1.9× 336 0.8× 393 1.0× 28 1.9k
Michael S. Simonson United States 33 1.0k 1.6× 525 0.9× 1.2k 2.6× 164 0.4× 316 0.8× 72 2.8k
Margot C. LaPointe United States 31 341 0.5× 830 1.4× 1.0k 2.2× 196 0.5× 168 0.4× 48 2.2k
Alex L. Loeb United States 21 636 1.0× 397 0.7× 492 1.1× 177 0.4× 164 0.4× 39 1.5k
G W Dorn United States 24 385 0.6× 728 1.2× 1.7k 3.8× 219 0.5× 162 0.4× 46 2.6k
Anna S. Belloni Italy 25 438 0.7× 352 0.6× 624 1.4× 323 0.7× 280 0.7× 90 1.9k
Hiroji Oida Japan 14 349 0.6× 195 0.3× 654 1.4× 235 0.5× 235 0.6× 19 2.1k

Countries citing papers authored by S Larkin

Since Specialization
Citations

This map shows the geographic impact of S Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Larkin more than expected).

Fields of papers citing papers by S Larkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Larkin. The network helps show where S Larkin may publish in the future.

Co-authorship network of co-authors of S Larkin

This figure shows the co-authorship network connecting the top 25 collaborators of S Larkin. A scholar is included among the top collaborators of S Larkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Larkin. S Larkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bishop‐Bailey, David, John Pepper, S Larkin, & Jane A. Mitchell. (1998). Differential Induction of Cyclooxygenase-2 in Human Arterial and Venous Smooth Muscle. Arteriosclerosis Thrombosis and Vascular Biology. 18(10). 1655–1661. 73 indexed citations
2.
Bishop‐Bailey, David, S Larkin, Timothy D. Warner, Gong Chen, & Jane A. Mitchell. (1997). Characterization of the induction of nitric oxide synthase and cyclo‐oxygenase in rat aorta in organ culture. British Journal of Pharmacology. 121(1). 125–133. 90 indexed citations
3.
Mitchell, Jane A., Frances M. K. Williams, T.J. Williams, & S Larkin. (1997). Role of nitric oxide in the dilator actions of capsaicin-sensitive nerves in the rabbit coronary circulation. Neuropeptides. 31(4). 333–338. 16 indexed citations
4.
Bishop‐Bailey, David, John Pepper, E B Haddad, et al.. (1997). Induction of Cyclooxygenase-2 in Human Saphenous Vein and Internal Mammary Artery. Arteriosclerosis Thrombosis and Vascular Biology. 17(9). 1644–1648. 55 indexed citations
5.
Wakelin, M, María‐Jesús Sanz, A Dewar, et al.. (1996). An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane.. The Journal of Experimental Medicine. 184(1). 229–239. 157 indexed citations
6.
Mitchell, Jane A., S Larkin, & Timothy J. Williams. (1995). Cyclooxygenase-2: Regulation and relevance in inflammation. Biochemical Pharmacology. 50(10). 1535–1542. 326 indexed citations
7.
Belvisi, Maria G., Peter J. Barnes, S Larkin, et al.. (1995). Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. European Journal of Pharmacology. 283(1-3). 255–258. 60 indexed citations
8.
Larkin, S, et al.. (1995). Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.. Journal of Pharmacology and Experimental Therapeutics. 272(1). 392–398. 10 indexed citations
9.
Warren, J. B., John Cockcroft, S Larkin, et al.. (1992). Pituitary Adenylate Cyclase Activating Polypeptide is a Potent Vasodilator in Humans. Journal of Cardiovascular Pharmacology. 20(1). 83–87. 24 indexed citations
10.
Warren, Jamie B., et al.. (1992). Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo. British Journal of Pharmacology. 106(2). 331–334. 59 indexed citations
11.
Clarke, John, et al.. (1991). Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.. Circulation. 83(3). 774–777. 30 indexed citations
12.
Clarke, John, S Larkin, Nigel Benjamin, et al.. (1989). Endothelin-1 Is a Potent Long-Lasting Vasoconstrictor in Dog Peripheral Vasculature in vivo. Journal of Cardiovascular Pharmacology. 13. S211–212. 17 indexed citations
13.
Chester, Adrian H., Michael R. Dashwood, John Clarke, et al.. (1989). Influence of endothelin on human coronary arteries and localization of its binding sites. The American Journal of Cardiology. 63(18). 1395–1398. 74 indexed citations
14.
Larkin, S, John Clarke, Bruce Keogh, et al.. (1989). Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. The American Journal of Cardiology. 64(14). 956–958. 67 indexed citations
15.
Benjamin, Nigel, et al.. (1989). Endothelin is a Potent Constrictor with Prolonged Action in Forearm Resistance Vessels and Veins in Man. Clinical Science. 76(s20). 1P–1P. 1 indexed citations
16.
Clarke, John, Nigel Benjamin, S Larkin, et al.. (1989). Endothelin is a potent long-lasting vasoconstrictor in men. American Journal of Physiology-Heart and Circulatory Physiology. 257(6). H2033–H2035. 106 indexed citations
17.
Crossman, David C., S Larkin, Richard W. Fuller, Graham J. Davies, & A Maseri. (1989). Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans.. Circulation. 80(3). 475–484. 65 indexed citations
18.
Larkin, S, et al.. (1988). Neuropeptide Y Reduces Dog Coronary Blood Flow without Reducing Epicardial Coronary Luminal Diameter. Clinical Science. 74(s18). 8P–9P. 1 indexed citations
19.
Clarke, John, et al.. (1987). Neuropeptide Y Reduces Dog Coronary Blood Flow by Increased Small Vessel Resistance. Clinical Science. 73(s17). 6P–6P. 2 indexed citations
20.
McEwan, Jean R., S Larkin, Sergio Chierchia, et al.. (1986). Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries.. Circulation. 74(6). 1243–1247. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideki Okunishi Breakdown of academic impact, for papers by Renhui Yang Breakdown of academic impact, for papers by Matthew J. Brody Breakdown of academic impact, for papers by Marie‐Hélène Séguélas Breakdown of academic impact, for papers by Michael S. Simonson Breakdown of academic impact, for papers by Margot C. LaPointe Breakdown of academic impact, for papers by Alex L. Loeb Breakdown of academic impact, for papers by G W Dorn Breakdown of academic impact, for papers by Anna S. Belloni Breakdown of academic impact, for papers by Hiroji Oida
Rankless by CCL
2026